Dexcom, Inc.

Other

Biolinq Incorporated

Richard Chien Yang

Apurv Ullas Kamath

Peter C Simpson

Mark C Brister

Michael Robert Mensinger

Eli Reihman

Katherine Yerre Koehler

Robert James Boock

Eric Cohen

Hari Hampapuram

Paul V Neale

Brian Christopher Smith

Naresh Chandra Bhavaraju

Jacob S Leach

Matthew D Wightlin

Thomas Arnold Peyser

Stephen J Vanslyke

David Michael Morelock

Mark Dervaes

Douglas William Burnette

Antonio C Llevares

Michael J Estes

Anna Leigh Davis

Ying Li

Aditya Sagar Mandapaka

Laura J Dunn

Nelson Quintana

John Michael Dobbles

Nicholas Polytaridis

Joshua Ray Windmiller

Scott M Belliveau

Benjamin Elrod West

Alexandra Elena Constantin

J Michael Dobbles

Subrai Girish Pai

David DeRenzy

Zebediah L McDaniel

Matthew Lawrence Johnson

Jared Rylan Tangney

Mohammad Ali Shariati

Vincent Peter Crabtree

Patrick Wile McBride

Michael Levozier Moore

Sumitaka Mikami

Stephen Alan Reichert

Beat Stadelmann

James Stephen Amidei

Philip Mansiel Pellouchoud

Deborah M Ruppert

Alan Steven Campbell

Sirilak Sattayasamitsathit

Minda McDorman Grucela

Darin Edward Chum Dew

Steven David King

Nasser Salamati

Robert Patrick Van Tassel

Pradnya Prakash Samant

Nassar Salamanti

Buddhadev Paul Chaudhuri

Joedin D Morelock

Abhishek Sharma

Dana Charles Cambra

Evan L Hsu

William C Hsu

Aarthi Mahalingham

Kho Braun

An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.

Integrated medicament delivery device for use with continuous analyte sensor

Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.

Analyte sensor

Described herein are variations of an analyte monitoring system, including an analyte monitoring device. For example, an analyte monitoring device may include an implantable microneedle array for use in measuring one or more analytes (e.g., glucose), such as in a continuous manner. The microneedle array may include, for example, at least one microneedle including a tapered distal portion having an insulated distal apex, and an electrode on a surface of the tapered distal portion located proximal to the insulated distal apex. At least some of the microneedles may be electrically isolated such that one or more electrodes is individually addressable.

Continuous analyte monitoring system with microneedle array

Briefly, a drinking set is provided that has a cup and a flow control disk set fully inside the cup. The flow control disk is constructed for creating a tortured flow path for any fluid flowing out of the cup. In this way, spills are substantially reduced or minimized, and the user has a stable and predictable sipping experience, even when the cup is jostled or violently moved. Fluid moving from the cup first hits a set of steeply angled entry fins, which absorb or reflect energy in the fluid. The fluid passes through a set of small entry openings, and flow to a set of exit fins, where the fluid strikes a face of the exit fins and changes direction to a set of larger exit openings. This tortured fluid path causes the drinking fluid to have a controlled flow and reduced kinetic energy as it approaches the user's mouth, multiple changes in flow direction, and provides several obstacles for absorbing kinetic energy and thus slowing the flow of the fluid.

Drink set having a calmed and restricted fluid flow

Systems and methods for continuous measurement of an analyte in a host are provided. The system generally includes a continuous analyte sensor configured to continuously measure a concentration of analyte in a host and a sensor electronics module physically connected to the continuous analyte sensor during sensor use, wherein the sensor electronics module is further configured to directly wirelessly communicate displayable sensor information to a plurality of different types of display devices.

Systems and methods for processing, transmitting and displaying sensor data

Systems and methods for processing sensor data and self-calibration are provided. In some embodiments, systems and methods are provided which are capable of calibrating a continuous analyte sensor based on an initial sensitivity, and then continuously performing self-calibration without using, or with reduced use of, reference measurements. In certain embodiments, a sensitivity of the analyte sensor is determined by applying an estimative algorithm that is a function of certain parameters. Also described herein are systems and methods for determining a property of an analyte sensor using a stimulus signal. The sensor property can be used to compensate sensor data for sensitivity drift, or determine another property associated with the sensor, such as temperature, sensor membrane damage, moisture ingress in sensor electronics, and scaling factors.

Advanced analyte sensor calibration and error detection

Growing community of inventors

Carlsbad, CA, United States of America

Richard Chien Yang